The CTSC is committed to education and training for the entire clinical and translational research team to better understand each other's disciplines, terminology, and approach to research or patients by developing, implementing, and coordinating multidisciplinary clinical and translational research education across partner institutions. Program topics now include regulatory issues, statistics and design, and design.
Informational Sessions for CTSC Resources
The CTSC offers educational opportunities for researchers and research study teams. All it takes is a phone call or email from a department, study team or researcher to make the request.
Seminars, short courses, and programs may take the form of webinars, regularly scheduled seminars, small group discussions, one-on-one meetings, or other approaches to meet the requester's needs.
Sample of our current offerings:
- Researchers, Take Advantage of CTSC Resources!
Description: CTSC Resource Service - Researchers from all partner institutions can more easily identify and access the CTSC's vast resources, both well-established but perhaps unknown and those newly developed.
- General Considerations for the Data Safety and Monitoring Board (DSMB)
- Research Data Management Series
A la carte menu option - choose one or more from this series
Description: Outlines an approach to managing data for research studies.
If there are other topics you would like to learn about, contact Carolyn Apperson-Hansen and ask. The CTSC is pleased to coordinate sessions to meet your needs.
SMART IRB is a platform designed to ease common challenges and burdens associated with initiating multisite research and provide a roadmap for institutions to implement the NIH Single IRB Review policy. Through a flexible master IRB reliance agreement, standard operating procedures, and complementary tools and resources, SMART IRB supports and encourages collaboration and harmonization across the nation.
For online help, such as SOP manuals, policies and FAQs visit the SMART IRB website.
A lack of adequate understanding of the requirements for commercialization and funding create major impediments to translation of bench research to the bedside. In support of CTSC efforts on innovation and education, the CTSC has partnered with the Cleveland Clinic to pilot an NSF I-Corps Hub for drug development (led by Dr. Ofer Reizes) in collaboration with the NIH National Center for Accelerated Innovations (NCAI) that includes CTSC partners across Cleveland and Ohio. Going forward we will use the I-Corps model to train investigators in the Lean Launchpad Business Model and coordinate with other skills development programs of the TWD office. Recently we have expanded our entrepreneur training with a CTSC guided program of venture mentoring (led by Dr. Mark Chance) modeled on the MIT VMS model. We are currently piloting the mentoring of four ventures and intend to expand to supporting 10 entrepreneurs a year from both our funded translational research programs and KL2 scholars cohorts
Regulatory & Compliance
The Food and Drug Administration has numerous regulations and guidance documents for investigators in their responsibilities for conducting FDA regulated research; investigators should have a thorough understanding of their role and responsibilities and how it relates to the protection of research participants. Research professionals are continuously challenged by the evolving regulatory landscape and the increased risk associated with the complexity of research protocols.
The CTSC can provide investigators with awareness of regulatory requirements and acceptable standards for the conduct of clinical trials and the protection of human subjects. We can help investigators understand the function of the FDA and Investigator responsibilities for those holding Investigational New Drug (IND) applications or Investigational Device Exemptions (IDE) or those investigators conducting research under and IND or IDE.
Clinical Investigators: View the September 2013 IND guidelines that have been recently been posted on the FDA/CDER website: [Investigational New Drug Applications (INDs) — Determining Whether Human Research Studies Can Be Conducted Without an IND].
IRB approval, IRB exemption or a “non-human subjects” research determination made by the IRB is required prior to the CTSA providing services for research involving human subjects, data and/or specimens.
The CTSC supports high quality, reproducible research across the spectrum of clinical and translational sciences by identifying efficient and cost effective ways in which to promote adherence to regulatory requirements and overall responsible conduct of research. Previously, the Regulatory Knowledge Support Core focused on: a) identifying common concerns related to the oversight of translational research, including institutional review processes perceived by investigators as "burdensome" and/or "redundant"; and b) defining and pilot testing new workflows, standard metrics and opportunities for inter-institutional collaboration.
While these efforts have promoted vital discourse between major local research entities in Cleveland, additional steps must be taken to translate these process improvement theories and pilot work flows into actionable items capable of supporting research network expansion, thus increasing the amount of "bench-to-bedside" and "bedside to community" research. The following aims will help synthesize its own unified efforts with those individually taken by CTSC partners to form a more centralized process improvement plan:
- Harmonize cross institutional policies and infrastructure to improve the quality of human subject protections and promote a clear culture of responsibility among CTSC investigators.
- Streamline regulatory review process to promote research collaboration, which will facilitate translation of scientific ideas to clinical practice.
- Provide innovative educational opportunities in Regulatory Sciences to complement and extend existing CTSC Regulatory offerings to all members of the translational workforce.
All CTSC partner institutions have robust research compliance programs and offices, and offer a full range of training on compliance topics such as:
- The Scientist as a Responsible Member of Society
- Conflict of Interest Disclosures
- Safe Laboratory Practices
- Human Subjects Protection
- Mentor/Mentee Responsibilities
- IND/IDE processes
- Collaborative Team Research
- Peer Review
- Responsible Conduct of Research
- Data Acquisition, Management
- Research Misconduct
- Responsible Authorship & Publication
Case Western Reserve University's Continuing Research Education Credit (CREC) Program provides investigators documented training in the protection of human subjects in research. The program is available to human subjects researchers at University Hospitals Cleveland Medical Center, The MetroHealth System, Case Western Reserve University, Louis Stokes Cleveland VA Medical Center, and The Cleveland Clinic. The Collaborative Institutional Training Initiative (CITI) is a training service to which the University subscribes. CITI provides comprehensive online educational programs in multiple areas including the protection of human subjects in research.
The NIH requires Responsible Conduct of Research (RCR) training at all CTSA institutions. Responsible Conduct of Research Guide to read an article about RCR training within the CTSA network entitled: "Instruction in the Responsible Conduct of Research: An Inventory of Programs and Materials within CTSAs."